Please note: this is a draft programme and therefore subject to change.

Day 1 – Tuesday 11th May: 12:00 – 18:20

12:00                Lunch
14:00                Welcome - Professor Robert Ali

The pharmacology of opioid safety
Treating opioid dependence in the context of HIV
Hidden risks: cardiac safety in opioid maintenance therapy
Drug–drug interactions in opioid dependence – Panel Discussion

SESSION 2: MANAGING THE UNEXPECTED: ACUTE THREATS TO PATIENT STABILITY

Revolving doors: at the interface between criminal justice and treatment services
Managing acute pain in opioid dependence
When treatment is not an option: evidence-based approaches to managed opioid withdrawal

Day 2 – Wednesday 12th May: 08:45 – 17:15

Ethics in opioid pharmacotherapy: are we doing all we can to maximise safety? – Safety Workshop

SESSION 3: MAXIMISING ACCESS: MINIMISING RISKS

French solution for global export?
Office-based prescribing: the US story
Optimising outcomes with shared care
Examining the abuse liability of maintenance medications for opioid dependence
Maximising access: a tale of morality, politics and pharmacology
Widening access to treatment – Panel Discussion

Splitting hairs: chronic pain, analgesic addiction and pharmacotherapy
Serious psychiatric comorbidities in opioid dependence
HIV and HCV in an opioid-dependent patient

Day 3 –Thursday 13th May: 08:40 – 13:45

Panel discussion

SESSION 5: CRITICAL DIFFERENCES IN THE CLINICAL CONTEXT

Critical differences in pharmacology
How to transition safely between opioids
Treating him, treating her: ORT and gender
Fundamental differences: the treatment experience
The STEP model
Best practice in treatment selection – Panel Discussion